We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$17.8B
AUM Growth
+$1.56B
Cap. Flow
+$1.29B
Cap. Flow %
7.26%
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Industrials 7.93%
3 Consumer Discretionary 7.91%
4 Financials 7.65%
5 Healthcare 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLG
3326
DELISTED
Allego N.V.
ALLG
-38,449
Closed -$55K
SPWR
3327
DELISTED
SunPower Corporation Common Stock
SPWR
-46,109
Closed -$138K
IMAQW
3328
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$0 ﹤0.01%
+31,712
New +$577
FREE
3329
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
-66,906
Closed -$323K
CALB
3330
DELISTED
California BanCorp Common Stock
CALB
-17,746
Closed -$390K
SLNAW
3331
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$0 ﹤0.01%
43,701
-4,113
-9% -$41
BNKU
3332
DELISTED
MicroSectorsTM U.S. Big Banks Index 3X Leveraged ETNs
BNKU
-9,011
Closed -$280K
BLUA.WS
3333
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$0 ﹤0.01%
28,111
+12,445
+79% +$648
EVBG
3334
DELISTED
Everbridge, Inc. Common Stock
EVBG
-84,483
Closed -$2.94M
TCON
3335
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-2,718
Closed -$23K
BRSH
3336
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
-267,101
Closed -$14K
VCXB.WS
3337
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
-14,129
Closed
HGASW
3338
DELISTED
Global Gas Corporation Warrant
HGASW
-145,758
Closed -$5K
COOLW
3339
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
-62,901
Closed -$9K
ADTH
3340
DELISTED
AdTheorent Holding Co
ADTH
-86,571
Closed -$277K
BIOL
3341
DELISTED
Biolase, Inc.
BIOL
-101,143
Closed -$19K
AONCW
3342
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-18,750
Closed -$6K
TWLVW
3343
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
-24,967
Closed -$2K
VTRU
3344
DELISTED
Vitru Limited Common Shares
VTRU
-36,780
Closed -$530K
FUSN
3345
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-17,911
Closed -$381K
GRTX
3346
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-15,782
Closed -$2K
SWAV
3347
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-22,083
Closed -$7.19M
ERF
3348
DELISTED
Enerplus Corporation
ERF
-380,034
Closed -$7.47M
BREZR
3349
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
-10,726
Closed -$2K
BREZW
3350
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
-14,261
Closed -$17K

Similar funds

HRT Financial's Q2 2024 Portfolio in Review

As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.

  • HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
  • HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
  • HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
  • HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
  • HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
  • HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
  • HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.